Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Stopped early · Not applicable · Has a placebo group

Conditions studied: Stroke

In brief

This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.

Key facts

Study ID

NCT02461355

Run by

Columbia University

People needed

2

Starts

2015-06-01

Expected to finish

2016-06-01

Last updated by the study team

2019-05-09

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age over 21 years
• Ischemic left hemispheric stroke verified by imaging (CT or MRI) greater than 6 months ago
• Residual non-fluent or anomic aphasia, with Western Aphasia Battery-Revised Aphasia Quotient score <60
• Fluent English speaker prior to stroke
• Right-handed prior to stroke
• Ability to give informed consent and understand the tasks involved.

You may not qualify if…

• History of recurrent stroke, either ischemic or hemorrhagic, in the left middle cerebral artery territory
• Imaging unavailable
• Large middle cerebral artery infarct involving entire inferior division (temporo-parietal) territory
• History of dementia prior to the stroke
• History of seizure, prior electroconvulsive therapy, deep brain stimulators, or brain surgery
• Social and/or personal circumstances that interfere with ability to return for therapy and assessment sessions.

Where it is running

• Adler Aphasia Center — Maywood, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.